No Current Details on Citigroup's Wealth Unit Sale to iCapital

Published 13 hours agoC

No Current Details on Citigroup's Wealth Unit Sale to iCapital

As of May 13, 2025, there is no publicly available information concerning Citigroup's sale of its wealth alternatives unit to the fintech firm iCapital. The absence of concrete details about this potential transaction means speculation remains just that—speculation.

In related news, iCapital announced on October 30, 2024, its plans to acquire AltExchange, a company known for its AI-driven technology in alternative investment data management, according to BusinessWire. Additionally, iCapital launched the iCapital Marketplace on June 14, 2023, designed to provide a platform for financial advisors to tap into alternative investment opportunities.

Furthermore, on November 27, 2023, DWS announced a partnership with iCapital aimed at offering global alternative asset strategies to the U.S. private wealth sector. These efforts highlight iCapital's strategic focus on growing its footprint within the alternative investment space, even as specific details about any deal with Citigroup remain unspecified.

Share this article

Twitter Facebook LinkedIn

Recent Articles

Sony Projects Slight Profit Increase Amid Tariff Challenges

Sony Projects Slight Profit Increase Amid Tariff Challenges

12 minutes agoSONY

Sony Group has projected a modest 0.3% rise in operating profit, anticipating a total of 1.28 trillion yen ($8.7 billion) for the fiscal year ending March 2026. This estimation accounts for a significant 100 billion yen impact from U.S. trade tariffs, posing a challenge to the company's financial performance. Sony's operating profit rose impressively by 16% to reach 1.4 trillion yen in the year ending March 2025, exceeding analysts' forecasts, according to Reuters. Major strategic moves include a shift under CEO Hiroki Totoki towards entertainment ventures such as gaming, movies, music, and chip production, coupled with a plan to partially spin off their financial unit by October, reducing their ownership to below 20%. To address pricing pressures, Sony has raised the cost of its PlayStation 5 in markets like Europe and Britain by roughly 10–11%, attributing this to inflation and currency fluctuations. Additionally, Sony projects a 16% growth in its gaming segment this year, spurred on by the imminent launch of "Ghost of Yotei," despite potential challenges from the delayed release of "Grand Theft Auto VI."

UnitedHealth Group Welcomes Stephen Hemsley Back as CEO

UnitedHealth Group Welcomes Stephen Hemsley Back as CEO

UnitedHealth Group has named Stephen Hemsley as its new Chief Executive Officer, effective immediately. This change comes following the abrupt resignation of Andrew Witty, who stepped down for personal reasons. Hemsley, who previously led the company from 2006 to 2017 and serves as chairman, now returns to guide UnitedHealth through this transition, according to AP News. The health insurance giant has recently withdrawn its financial forecast for 2025, citing increasing medical costs attributed to an influx of new Medicare Advantage members. This unexpected move led to a significant 16% drop in the company's share value. These financial challenges are compounded by a series of setbacks, as reported by Reuters, including the tragic murder of executive Brian Thompson in December and a cyberattack that compromised sensitive data. With Hemsley back at the helm, UnitedHealth aims to tackle these pressing internal issues with renewed urgency. The company has publicly stated its commitment to addressing these challenges and stabilizing its operations in the wake of recent disruptions.

Vaxart Secures Funding and Advances Vaccine Trials

Vaxart Secures Funding and Advances Vaccine Trials

3 hours agoVXRT

Vaxart, Inc., a biotech company known for its innovative vaccine programs, has announced that it has secured sufficient funding to extend its operational cash runway into the first quarter of 2026. This financial boost is critical for sustaining the development of its vaccine initiatives and ensuring ongoing operations in the years to come. In addition to its bolstered financial position, Vaxart is making strides with its oral COVID-19 vaccine program. The company is preparing for a substantial Phase 2b clinical trial that will involve 10,000 participants and will compare the efficacy of its oral vaccine candidate against an existing mRNA vaccine. This trial represents a significant step forward in the COVID-19 vaccine landscape. Also, Vaxart is advancing its oral norovirus vaccine, having recently started a Phase 1 trial focused on lactating mothers and reporting positive Phase 2 trial results that demonstrate strong immunogenicity and a favorable safety profile. These developments highlight Vaxart’s ongoing commitment to its vaccine pipeline while ensuring a stable financial footing. As Reuters reported, these strategic moves come at a time when the company's stock price is hovering around $0.4155, with recent trading activity indicating a slight change of $0.01 (0.02%) from the prior closing price. Vaxart continues to navigate a competitive market, marked by a recent intraday high of $0.4799.

Pixelworks Targets Shanghai Subsidiary Profitability with Strategic Initiatives

Pixelworks Targets Shanghai Subsidiary Profitability with Strategic Initiatives

4 hours agoPXLW

Pixelworks has unveiled a series of strategic moves designed to boost the profitability of its Shanghai subsidiary and enhance its TrueCut Motion platform. These initiatives include a 10% reduction in operating expenses as part of broader cost-saving measures, which the company expects to be fully realized by the end of the second quarter of 2025. Pixelworks Shanghai has also earned the "Little Giant" certification from China's Ministry of Industry and Information Technology. This prestigious designation not only signifies recognition as a leading enterprise with significant growth potential but also opens doors to government subsidies. Additionally, Pixelworks secured a multi-year deal with Universal Pictures to incorporate its TrueCut Motion technology into upcoming theatrical releases, aiming to improve visual effects and boost revenue. The company is actively assessing strategic options for its Shanghai unit through a comprehensive review process, exploring various ownership and collaboration structures. These efforts collectively aim to position Pixelworks Shanghai for sustained growth and profitability by 2025. Reuters reported that these initiatives are part of Pixelworks' broader strategy to maximize long-term growth and shareholder value.